IL134156A0 - Alatrofloxacin parenteral compositions - Google Patents

Alatrofloxacin parenteral compositions

Info

Publication number
IL134156A0
IL134156A0 IL13415698A IL13415698A IL134156A0 IL 134156 A0 IL134156 A0 IL 134156A0 IL 13415698 A IL13415698 A IL 13415698A IL 13415698 A IL13415698 A IL 13415698A IL 134156 A0 IL134156 A0 IL 134156A0
Authority
IL
Israel
Prior art keywords
alatrofloxacin
parenteral compositions
parenteral
compositions
alatrofloxacin parenteral
Prior art date
Application number
IL13415698A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL134156A0 publication Critical patent/IL134156A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
IL13415698A 1997-08-01 1998-07-23 Alatrofloxacin parenteral compositions IL134156A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5424697P 1997-08-01 1997-08-01
PCT/IB1998/001122 WO1999006430A1 (en) 1997-08-01 1998-07-23 Alatrofloxacin parenteral compositions

Publications (1)

Publication Number Publication Date
IL134156A0 true IL134156A0 (en) 2001-04-30

Family

ID=21989735

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13415698A IL134156A0 (en) 1997-08-01 1998-07-23 Alatrofloxacin parenteral compositions

Country Status (40)

Country Link
US (1) US6194429B1 (xx)
EP (1) EP1000086B1 (xx)
JP (1) JP3463928B2 (xx)
KR (1) KR20010022495A (xx)
CN (1) CN1265671A (xx)
AP (1) AP1031A (xx)
AR (1) AR015417A1 (xx)
AT (1) ATE259827T1 (xx)
AU (1) AU734863B2 (xx)
BG (1) BG104105A (xx)
BR (1) BR9811580A (xx)
CA (1) CA2296466C (xx)
CO (1) CO4970688A1 (xx)
DE (1) DE69821767T2 (xx)
DK (1) DK1000086T3 (xx)
DZ (1) DZ2576A1 (xx)
EA (1) EA002120B1 (xx)
ES (1) ES2214716T3 (xx)
GT (1) GT199800112A (xx)
HN (1) HN1998000106A (xx)
HR (1) HRP980417B1 (xx)
HU (1) HUP0004793A3 (xx)
ID (1) ID24374A (xx)
IL (1) IL134156A0 (xx)
IS (1) IS5339A (xx)
MA (1) MA24626A1 (xx)
NO (1) NO20000485L (xx)
NZ (1) NZ502249A (xx)
OA (1) OA11281A (xx)
PA (1) PA8456701A1 (xx)
PE (1) PE103799A1 (xx)
PL (1) PL338477A1 (xx)
PT (1) PT1000086E (xx)
SK (1) SK1012000A3 (xx)
TN (1) TNSN98146A1 (xx)
TW (1) TW538043B (xx)
UY (1) UY25113A1 (xx)
WO (1) WO1999006430A1 (xx)
YU (1) YU2500A (xx)
ZA (1) ZA986874B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR025976A1 (es) * 1999-10-08 2002-12-26 Affinium Pharm Inc Inhibidores de fab i.
EP1121933A1 (en) * 2000-02-02 2001-08-08 Pfizer Products Inc. Premixed alatrofloxacin injectable compositions
WO2003088897A2 (en) 2001-04-06 2003-10-30 Affinium Pharmaceuticals, Inc. Fab i inhibitors
ES2518316T3 (es) 2002-12-06 2014-11-05 Debiopharm International Sa Compuestos heterocíclicos, métodos de fabricación de los mismos y su uso en terapia
EP1608377B1 (en) 2003-03-17 2008-10-01 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
CA2467321A1 (en) * 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
DK1828167T3 (da) * 2004-06-04 2014-10-20 Debiopharm Int Sa Acrylamidderivater som antibiotiske midler
WO2007067416A2 (en) * 2005-12-05 2007-06-14 Affinium Pharmaceuticals, Inc. Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
JP5468899B2 (ja) 2006-07-20 2014-04-09 アフィニウム ファーマシューティカルズ, インク. Fabiインヒビターとしてのアクリルアミド誘導体
EP3255045A1 (en) 2007-02-16 2017-12-13 Debiopharm International SA Salts, prodrugs and polymorphs of fab i inhibitors
TR201909016T4 (tr) 2012-06-19 2019-07-22 Debiopharm Int Sa (E)-n-metil-n-((3-metilbenzofuran-2-il)metil)-3-(7-okso-5,6,7,8-tetrahidro-1,8-naftiridin-3-il)akrilamidin ön ilaç türevleri.
BR112016024841A2 (pt) * 2014-04-25 2017-10-24 Naurex Inc composições estáveis de peptídeos neuroativos
AU2017223037B2 (en) 2016-02-26 2022-04-14 Debiopharm International S.A. Medicament for treatment of diabetic foot infections
WO2019148294A1 (en) 2018-02-02 2019-08-08 Interface Biologics, Inc. Dimeric dexamethasone prodrug compositions and uses thereof
CA3176134A1 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3713672A1 (de) 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5256791A (en) 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
BR9408490A (pt) 1994-01-18 1997-08-26 Pfizer Processo e intermediários para a preparação de sais do ácido nafftiridonocarboxílico
TW420610B (en) 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
US5475116A (en) 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
ES2117426T3 (es) 1995-06-06 1998-08-01 Pfizer Forma cristalina de la sal anhidra compuesta de los acidos 7-((1a,5a,6a)-6-amino-3-azabiciclo(3.1.0.)hex-3-il)-6-fluoro-1-(2,4-difluorofenil)-1,4-dihidro-4-oxo-1,8-naftiridina-3-carboxilico y metanosulfonico.
DK0833837T3 (da) * 1995-06-15 2002-09-02 Pfizer Fremgangsmåde til fremstilling af derivater af azabicyclonaphthydridincarboxylsyre omfattende et dipeptid
RU2151152C1 (ru) 1995-08-29 2000-06-20 Пфайзер Инк. Полиморфы 6-n-(l-ala-l-ala)-тровафлоксацина
KR100343909B1 (ko) 1995-08-29 2003-04-10 화이자 인코포레이티드 트로바플록사신의쯔비터이온형태
GB9524466D0 (en) 1995-11-30 1996-01-31 Pfizer Ltd Process
JPH1087617A (ja) 1996-07-09 1998-04-07 Pfizer Inc キノリン系抗生物質の合成に有用な中間体の製法

Also Published As

Publication number Publication date
CA2296466A1 (en) 1999-02-11
NO20000485D0 (no) 2000-01-31
YU2500A (sh) 2002-09-19
PT1000086E (pt) 2004-05-31
EA002120B1 (ru) 2001-12-24
HUP0004793A3 (en) 2001-10-29
AP1031A (en) 2001-12-21
ES2214716T3 (es) 2004-09-16
HRP980417A2 (en) 1999-08-31
UY25113A1 (es) 2000-12-29
CN1265671A (zh) 2000-09-06
KR20010022495A (ko) 2001-03-15
AU734863B2 (en) 2001-06-21
GT199800112A (es) 2000-01-15
HUP0004793A2 (hu) 2001-04-28
HN1998000106A (es) 1999-01-08
ID24374A (id) 2000-07-13
PA8456701A1 (es) 2000-05-24
CO4970688A1 (es) 2000-11-07
NZ502249A (en) 2001-11-30
IS5339A (is) 2000-01-14
JP2001512133A (ja) 2001-08-21
WO1999006430A1 (en) 1999-02-11
DE69821767T2 (de) 2005-01-13
TNSN98146A1 (fr) 2005-03-15
EA200000086A1 (ru) 2000-08-28
AP9801310A0 (en) 1998-09-30
PL338477A1 (en) 2000-11-06
TW538043B (en) 2003-06-21
DE69821767D1 (de) 2004-03-25
MA24626A1 (fr) 1999-04-01
JP3463928B2 (ja) 2003-11-05
OA11281A (en) 2002-11-19
CA2296466C (en) 2003-04-15
AU8236898A (en) 1999-02-22
SK1012000A3 (en) 2000-09-12
ATE259827T1 (de) 2004-03-15
DZ2576A1 (fr) 2003-02-22
NO20000485L (no) 2000-03-27
AR015417A1 (es) 2001-05-02
EP1000086A1 (en) 2000-05-17
DK1000086T3 (da) 2004-05-17
EP1000086B1 (en) 2004-02-18
US6194429B1 (en) 2001-02-27
ZA986874B (en) 2000-01-31
BG104105A (bg) 2000-08-31
BR9811580A (pt) 2000-08-22
HRP980417B1 (en) 2002-10-31
PE103799A1 (es) 1999-10-25

Similar Documents

Publication Publication Date Title
HUP9903759A3 (en) Abtimicrobial compositions
GB9726814D0 (en) Compositions
GB9702238D0 (en) Compositions
GB9704524D0 (en) Composition
IL134156A0 (en) Alatrofloxacin parenteral compositions
GB9716152D0 (en) Improved table
IL130856A0 (en) Peroxetine compositions
GB9726543D0 (en) Novel compositions
PL336038A1 (en) Pharmaceutic compositions
PL338017A1 (en) Novel composition
EP0958806A4 (en) HAIR COLORING COMPOSITION
GB9724838D0 (en) Compositions
GB9701031D0 (en) Composition
GB9705340D0 (en) Compositions
GB9703109D0 (en) Compositions
PL335729A1 (en) Pharmaceutic compositions
GB9705813D0 (en) Novel compositions
GB9712981D0 (en) Compositions
GB2336368B (en) Compositions
GB9717523D0 (en) Compositions
GB9703375D0 (en) Compositions
GB9704799D0 (en) Compositions
GB9704427D0 (en) Compositions
GB9703611D0 (en) Compositions
GB9708467D0 (en) Compositions